Limited-Edition Violent Gentlemen Hockey Club Tees Benefiting the CureDuchenne. Your purchase makes a difference.Every tee supports CureDuchenne’s mission to improve the lives of everyone affected by Duchenne muscular dystrophy—by accelerating […]
Results published in the Annals of Clinical and Translational Neurology show that long-term treatment with givinostat, a histone deacetylase (HDAC) inhibitor, in combination with corticosteroids, delayed disease progression in ambulant individuals with […]
Luncheon and Fashion Presentation, Produced and Sponsored by South Coast Plaza, Funds Transformative Duchenne Muscular Dystrophy Research NEWPORT BEACH, California (August 21, 2025) – CureDuchenne, a global nonprofit dedicated […]
Developing a novel therapeutic designed to protect muscle in Becker and Duchenne muscular dystrophy Watch HERE
Legacy Giving August is Make-a-Will Month — the perfect time to reflect on how you can protect what matters most: your loved ones and the causes that hold a special […]
In this webinar, Dr. Naz Dastgir, Executive Medical Director and Clinical Development Lead for RGX-202 at REGENXBIO, shared information on the active and enrolling AFFINITY DUCHENNE trial and how families […]
Solid Biosciences announced a widely anticipated update on their INSPIRE DUCHENNE Phase 1/2 clinical trial of SGT-003, their investigational micro-dystrophin gene therapy for Duchenne muscular dystrophy. What this means for […]
The FDA is continuing its review of Ataluren (Translarna), the first potential therapy specifically for individuals with nonsense mutation Duchenne (nmDMD). There is currently no set decision date. The application […]
When the Duchenne and Becker community speaks, the world listens — not just because of what you say, but because of how deeply it comes from the heart. In recent […]
